Respiri Limited Stock

Equities

RSH

AU000000RSH4

Advanced Medical Equipment & Technology

Delayed Australian S.E. 20:16:00 2024-04-29 EDT 5-day change 1st Jan Change
0.036 AUD +2.86% Intraday chart for Respiri Limited +2.86% +20.00%

Financials

Sales 2022 772K 507K 693K Sales 2023 658K 432K 590K Capitalization 32.11M 21.08M 28.8M
Net income 2022 -6M -3.94M -5.38M Net income 2023 -5M -3.28M -4.48M EV / Sales 2022 52.7 x
Net cash position 2022 1.18M 771K 1.05M Net cash position 2023 25.52K 16.75K 22.89K EV / Sales 2023 48.8 x
P/E ratio 2022
-6.04 x
P/E ratio 2023
-5.28 x
Employees 30
Yield 2022 *
-
Yield 2023
-
Free-Float 79.46%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.86%
1 week+2.86%
Current month+28.57%
1 month+24.14%
3 months+38.46%
6 months+12.50%
Current year+20.00%
More quotes
1 week
0.03
Extreme 0.032
0.04
1 month
0.03
Extreme 0.028
0.04
Current year
0.02
Extreme 0.021
0.04
1 year
0.02
Extreme 0.021
0.05
3 years
0.02
Extreme 0.021
0.13
5 years
0.02
Extreme 0.021
0.25
10 years
0.02
Extreme 0.021
0.28
More quotes
Managers TitleAgeSince
Chief Executive Officer - 19-11-24
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member - 22-06-19
Chief Executive Officer - 19-11-24
Chairman - 19-10-29
More insiders
Date Price Change Volume
24-04-29 0.036 +2.86% 144 327
24-04-29 0.035 +2.94% 426,391
24-04-26 0.034 +3.03% 213,903
24-04-24 0.033 -5.71% 766,913
24-04-23 0.035 0.00% 368,421

Delayed Quote Australian S.E., April 29, 2024 at 08:16 pm

More quotes
Respiri Limited is an Australia-based e-health software as a service company that supports respiratory health management. It is engaged in research, development and commercialization of medical devices, and the development of mobile health applications. Its Wheezo technology is a breath sensor (medical device) that works with the respiri mobile applications (patient user interface) to record and track wheeze. Wheezo is a smart device to help improve asthma management by monitoring wheeze and documenting symptoms, signs, triggers, weather conditions and medication use. The asthma management platform also facilitates the sharing of data with caregivers, physicians and other health care professionals. Wheezo is used to detect and record abnormal breath sounds (continuous adventitious breath sounds) in the windpipe (trachea), reported as WheezeRate in adults and children for more than two years. It also offers connected care solutions for management of people living with chronic diseases.
More about the company

Annual profits - Rate of surprise